Cleveland Biolabs Inc 7CB1-FF:Frankfurt Stock Exchange

RT Quote | Exchange | EUR
Last | 3:37 PM CET
4.62quote price arrow up+0.26 (+5.96%)
52 week range
1.29 - 12.50

...

Loading . . .

KEY STATS

  • Open4.80
  • Day High4.80
  • Day Low4.62
  • Prev Close4.36
  • 52 Week High12.50
  • 52 Week High Date02/18/21
  • 52 Week Low1.29
  • 52 Week Low Date06/09/20
  • Market Cap75.1M
  • Shares Out13.02M
  • 10 Day Average Volume1,369.6
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change83.33

RATIOS/PROFITABILITY

  • EPS (TTM)-0.17
  • P/E (TTM)-27.18
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Cleveland Biolabs Inc News

There is no recent news for this security.

Latest 7CB1-FF News From Our Partners

QUOTE FINDER

Profile

MORE
Cleveland BioLabs, Inc. (CBLI) is a biopharmaceutical company. The Company is engaged in developing approaches to activate the immune system and address serious medical needs. Its platform of Toll-like immune receptor activators has applications in mitigation of radiation injury and immuno-oncology. Its advanced product candidate is Entolimod, an immuno-stimulatory agent, which it is developing as a radiation countermeasure and an immunotherapy for oncology and other...
Lea Verny
Chairman
Christopher Zosh
Chief Executive Officer
Langdon Miller M.D.
President
Address
73 High St
Buffalo, NY
14203-1149
United States